Author

Viola Chitiyo

Observed names: Viola C. Chitiyo, Viola N. Chitiyo

Institution: Memorial Sloan Kettering Cancer Center

Observed institution: Memorial Sloan Kettering Cancer Center

OpenAlex ID: A5134434080

NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022

2022 · Deborah K. Armstrong, Ronald D. Alvarez, et al. · Journal of the National Comprehensive Cancer Network · 403

Basket study of the oral progesterone antagonist onapristone ER in women with progesterone receptor positive (PR+) recurrent granulosa cell tumor (GCT), low-grade serous ovarian cancer (LGSOC), or endometrioid endometrial cancer (EEC).

2020 · Rachel N. Grisham, Karen Li, et al. · Journal of Clinical Oncology · 2

A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor

2026 · Elizabeth E. Hopp, Danielle Enserro, et al. · Gynecologic Oncology

A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor

2026 · Elizabeth Hopp, Danielle Enserro, et al. · Gynecologic Oncology

Adjuvant dostarlimab with pelvic radiation (RT) in locally advanced, mismatch repair-deficient (MMR-D) endometrial cancer (EC): D-RT study

2026 · Ying Liu, Maria Rubinstein, et al. · Gynecologic Oncology

Works count: 5

Citation count: 405

H-index: 2

I10-index: 1